Exelon Corporation (EXC)
Exelon Corporation is one of the nation’s largest electric utilities. The company has one of the industry’s largest portfolios of electricity generation capacity, with a nationwide reach and strong positions in the Midwest and Mid-Atlantic. Exelon distributes electricity to the customers in northern Illinois and southeastern Pennsylvania and natural gas to the customers in the Philadelphia area.
Exelon Corporation (EXC)‘s Financial Overview
Exelon Corporation (EXC) surged 0.18% yesterday to close its trading session at $38.54. The company has 1 year Price Target of $41.88. Exelon Corporation has 52-Week high of $42.67 and 52-Week Low of $33.3. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 7.69 Million shares yesterday. The firm shows the market capitalization of $37.84 Billion.
Exelon Corporation (EXC) reported its last quarterly earnings on 12/30/2017 where the firm reported its Actual EPS of $0.55/share against the analyst consensus estimate of $0.6/share. The difference between the actual and expected EPS is $-0.05 a share with a surprise factor of -8.3%.
The firm is trading with SMA20 of 2.25 Percent, SMA50 of SMA50 Percent and SMA200 of 0.34 percent. Exelon Corporation has P/S value of 1.13 while its P/B value stands at 1.25. Similarly, the company has Return on Assets of 3.2 percent, Return on Equity of 13.5 percent and Return on Investment of 6.3 Percent. The company shows Gross Margin and Operating Margin of 58.1 percent and 12 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 2 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 18 analysts offering 12-month price forecasts for Exelon Corp have a median target of 43.00, with a high estimate of 50.00 and a low estimate of 33.00. The median estimate represents a +11.57% increase from the last price of 38.54.
BioAmber Inc. (BIOA)
BioAmber Inc. is a bio-based chemicals company. It produces and sells bio-succinic acid. The company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstock into chemicals for use in products including plastics, resins, food additives and personal care products. It operates in France, China, Canada, and the United States. BioAmber Inc. is based in Plymouth, Minnesota.
BioAmber Inc. (BIOA)’s Financial Outlook
The 2 analysts offering 12-month price forecasts for BioAmber Inc have a median target of 6.50, with a high estimate of 12.00 and a low estimate of 1.00. The median estimate represents a +14,473.99% increase from the last price of 0.04.
According to Zacks Investment Research, BioAmber Inc. has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged17.37% and closed its last trading session at $0.04. The company has the market capitalization of $2.4 Million. The stock has 52-week high of $2.88 and 52-Week low of $0. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 7.66 Million shares. The company has a total of 53.87 Million shares outstanding.
BioAmber Inc. (BIOA) in the last quarter reported its actual EPS of $-0.15/share where the analyst estimated EPS was $-0.18/share. The difference between the actual and Estimated EPS is $0.03. This shows a surprise factor of 16.7 percent.
The company has YTD performance of -88.85 percent. Beta for BioAmber Inc. stands at 2.59 while its ATR (average true range) is 0.01. The company has Weekly Volatility of 19.03%% and Monthly Volatility of 18.38%.
BioAmber Inc. has distance from 20-day Simple Moving Average (SMA20) of -5.83%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of -94.27%.
The Company currently has ROA (Return on Assets) of -15.8 percent, Return on Equity (ROE) of -33.5 Percent and Return on Investment (ROI) of -25.7% with Gross margin of -76 percent.